Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by Hideawayon Oct 11, 2022 2:39pm

RE:Put pressure on the company

Hard to understand the decision making process at IMV.I emailed them but got a responce that they couldn't provide details due to upcoming conference presentation.They did not indicate which ...more  
288
User Avatar Image
(2)
•••
  • bikkel78X
Post by bikkel78on Oct 05, 2022 2:52am

Put pressure on the company

Sad to see they made the decision to save the prelim DLBCL data for a conference. Seems like they prefer scientists over shareholders. Time for action. Please send a mail to ddavan@imv-inc.com or ...more  
529
User Avatar Image
(20)
•••
  • antisenseX
Comment by antisenseon Sep 30, 2022 10:36am

RE:RE:VITALIZE Update!!??

I hope you are right.  They lead investors to beleive the first round of early results would be released end of Q3 2022 in their: Second Quarter 2022 Financial and Operational Results " ...more  
368
User Avatar Image
(2)
•••
  • bikkel78X
Comment by bikkel78on Sep 30, 2022 10:04am

RE:VITALIZE Update!!??

IMV is announcing that they will present the data in a scientific conference early 2023 which is to be seen as a positive news.  Unfortunately these conferences do not accept presentations ...more  
315
User Avatar Image
(20)
•••
  • antisenseX
Post by antisenseon Sep 30, 2022 9:56am

VITALIZE Update!!??

What kind of trial update was that??!!  "We are providing an Update on the VITALIZE trial in order to check off the box that we said we'd provide ann update on the VITALIZE trial around ...more  
326
User Avatar Image
(3)
•••
  • antigua1987X
Post by antigua1987on Sep 29, 2022 3:43pm

dlbcl data 3Q

any results reported in next few days are likely so preliminary that mrkt's going to be less than enthused. Just too early for meaningful data.
192
User Avatar Image
(2)
•••
  • europe10X
Post by europe10on Sep 29, 2022 12:10pm

last chance?

Tic tac,  DLBCL results should be out soon, or? "3rd quarter" Hmmmmm 7/8 patients reported ORR before If IMV can repeat that, or close to those figures, it will be superb results. That ...more  
291
Post by Aimvexon Sep 18, 2022 11:16am

Imv restructuring

Imv has laid off 30% of It's work force calling it strategical restructuring. In my perspective leader of this company doesn't know what he is doing and where they are headed.!
381
User Avatar Image
(2)
•••
  • BreakthoroughX
Post by Breakthoroughon Sep 17, 2022 4:53am

Interview

This interview with Matasar (in charge of VITALIZE trial) looks pretty optimistic. I would highlight this, because he calls VITALIZE a PIVOTAL trial: "This is a pivotal clinical trial that we ...more  
525
User Avatar Image
(1)
•••
  • JoefromDCX
Comment by JoefromDCon Sep 16, 2022 11:25am

RE:Anyone buying IMV today will double their money easy.

That's good cause I already lost half
95
User Avatar Image
(38)
•••
  • driller1aX
Post by driller1aon Sep 14, 2022 3:58pm

Anyone buying IMV today will double their money easy.

More than likely by the end of this year.
197
User Avatar Image
(2)
•••
  • BreakthoroughX
Comment by Breakthoroughon Sep 12, 2022 10:49am

RE:RE:RE:RE:RE:RE:RE:RE:Interesting (and hidden) data

It is here: https://www.imv-inc.com/the-dpx-platform/scientific-publications-posters
213
Comment by Hideawayon Sep 12, 2022 10:45am

RE:RE:RE:RE:RE:RE:RE:Interesting (and hidden) data

Thanks Breakthrough.The wording on their tweet was what confused me.If it was just a repeat of the August 22 presentation,there would be no new info given in the ESMO presentation. Is the PDF you ...more  
173
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next